Discrepancy between the European clinical guidelines and myocardial revascularization in patients with stable coronary artery disease in Russia

被引:1
|
作者
Kiselev, Anton R. [1 ]
Korotin, Alexey S. [1 ]
Posnenkova, Olga M. [1 ]
Popova, Yulia V. [1 ]
Prokhorov, Mikhail D. [2 ]
Gridnev, Vladimir I. [1 ]
机构
[1] Saratov State Med Univ, Dept New Cardiol Informat Technol, Res Inst Cardiol, 112 Bolshaya Kazachya Str, Saratov 410012, Russia
[2] Russian Acad Sci, Saratov Branch, Lab Nonlinear Dynam Modelling, Inst Radio Engn & Elect, Saratov 410019, Russia
关键词
coronary artery disease; myocardial revascularization; ESC; EACTS guidelines; clinical indications; OPTIMAL MEDICAL THERAPY; ISCHEMIC-HEART-DISEASE; BYPASS GRAFT-SURGERY; INTERVENTION; MANAGEMENT; LIFE; PCI;
D O I
10.1093/intqhc/mzy140
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines, six indications have been proposed for making a decision on myocardial revascularization in patients with stable coronary artery disease (CAD). Our aim was to study a discrepancy between the actual clinical situation and ESC/EACTS indications on performing the revascularization in patients with CAD in Russia. We used retrospective clinical data on patients with stable CAD enrolled in the 20122015 Russian Registry of Hypertension, Coronary Artery Disease, and Chronic Heart Failure. A total of 1522 patients with CAD (aged 53.0 8.5 years, 76.2% male) were used for analysis. All patients were divided into two groups: 591 patients with performed myocardial revascularization (named as R-CAD) and 931 patients refused from revascularization (named as NR-CAD). Factors associated with revascularization performance were identified by discriminant function analysis. ESC/EACTS indications for revascularization were assessed. A total of 1196 patients with CAD had any ESC/EACTS indication for revascularization, but only 40.2% of them had performed invasive coronary intervention. Myocardial revascularization was appropriate in 81.4% of R-CAD patients and 76.8% of NR-CAD patients. The main factor of revascularization performance was any stenosis > 50% and grades IIIIV of stable angina. With non-performed revascularization, the following factors were associated: limiting angina or angina equivalent, unresponsive to medical therapy, atherosclerotic peripheral arterial disease and increasing the New York Heart Association class of chronic heart failure. Most ESC/EACTS indications had little effect on decision-making on revascularization. There is a discrepancy between the actual clinical situation and ESC/EACTS guidelines on myocardial revascularization in patients with stable CAD in Russia.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 50 条
  • [31] Effect of extracorporeal shockwave myocardial revascularization on spatial QRS - Tangle resolution in stable coronary artery disease patients
    Saboe, A.
    Surjadi, P.
    Tiksnadi, B. B.
    Martanto, E.
    Purnomowati, A.
    Aprami, T. M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0B) : B23 - B23
  • [32] The comparison of clinical outcomes between incomplete revascularization and complete revascularization in the coronary artery disease
    Li, Jiehui
    Hua, Kun
    Yang, Xiubin
    CARDIOLOGY, 2014, 129 : 70 - 70
  • [33] Complete Coronary Revascularization: A New Strategy to Improve Clinical Outcomes for Stable Coronary Artery Disease?
    Leopold, Jane A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (12) : 1189 - 1191
  • [34] Initial clinical results of percutaneous myocardial laser revascularization to treat patients with endstage coronary artery disease
    Thew, ST
    Tessalee, M
    Oswald, KA
    Schaer, GL
    Snell, RJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) : 239A - 239A
  • [35] Impact of myocardial viability and coronary revascularization on clinical outcome and prognosis: An observational study in 161 patients with coronary artery disease
    vomDahl, J
    Altehoefer, C
    Buchin, P
    Sheehan, FH
    Schwarz, ER
    Koch, KC
    Schulz, G
    Uebis, R
    Schondube, F
    Messmer, BJ
    Bull, U
    Hanrath, P
    ZEITSCHRIFT FUR KARDIOLOGIE, 1996, 85 (11): : 868 - 881
  • [36] DISCREPANCIES BETWEEN CINEANGIOGRAPHIC AND POSTMORTEM FINDINGS IN PATIENTS WITH CORONARY-ARTERY DISEASE AND RECENT MYOCARDIAL REVASCULARIZATION
    GRONDIN, CM
    DYRDA, I
    PASTERNAC, A
    CAMPEAU, L
    BOURASSA, MG
    LESPERANCE, J
    CIRCULATION, 1974, 49 (04) : 703 - 708
  • [37] Myocardial revascularization in patients with coronary artery disease and end-stage renal disease
    Gradaus, F
    Schoebel, FC
    Ivens, K
    Heering, P
    Strauer, BE
    Leschke, M
    PERFUSION, 1996, 9 (12): : 428 - 432
  • [38] Kawasaki disease, myocardial infarction and coronary artery revascularization
    Wong, D
    Harder, J
    Jadavji, T
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (07) : 601 - 604
  • [39] MYOCARDIAL REVASCULARIZATION FOR CORONARY-ARTERY OCCLUSIVE DISEASE
    GEHA, AS
    LAKS, H
    HAMMOND, GL
    CONNECTICUT MEDICINE, 1980, 44 (06) : 344 - 348
  • [40] Effect of rosuvastatin therapy and myocardial revascularization on angiogenesis in coronary artery disease patients
    Semenova, A. E.
    Sergienko, I. V.
    Masenko, V. P.
    Gabrusenko, S. A.
    Kukharchuk, V. V.
    Belenkov, Yu. N.
    KARDIOLOGIYA, 2007, 47 (11) : 4 - 8